Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Filings indexed 706 across all filing types
Latest filing 2025-07-25 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-25 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about the date of an upcoming Board Meeting scheduled to consider and approve the un-audited quarterly financial results for the quarter ended June 30, 2025. It also mentions the closure of the trading window as per insider trading regulations. The document does not contain any financial data or results itself, nor does it include the actual financial report. It is an announcement of the date of a board meeting related to financial results, which is a regulatory disclosure under SEBI regulations. The document length is short (2161 characters), and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2025-07-25 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2025. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and compliance with regulatory requirements. The document is short (3452 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or management discussion but is a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2025-07-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure of shareholding under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. It is a declaration by a promoter about shareholding and encumbrance status during the financial year ended 31 March 2025. The content focuses on shareholding disclosures and promoter group details, not on financial results, management changes, or other report types. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes or disclosures in significant share ownership levels. The document length is short and it is a direct disclosure, not an announcement or report publication. Therefore, the correct classification is MRQ with high confidence.
2025-06-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) notifying the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the trading window closure period around the announcement of quarterly financial results but does not contain any financial data or results itself. The document is an announcement related to regulatory compliance and insider trading restrictions rather than a financial report or earnings release. The document length is short (1942 characters), and it serves as an intimation rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance notifications and announcements that do not fit other specific categories.
2025-06-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the withdrawal of a previously proposed Scheme of Amalgamation between Gujarat Themis Biosyn Limited and Themis Medicare Limited. The text includes references to board resolutions, regulatory compliance, and the decision not to proceed with the merger scheme. There are no financial statements, detailed financial analysis, or earnings data present. The document is an official announcement regarding a corporate action (withdrawal of a merger scheme) rather than a full report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-06-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.